Vaccine diversity emerges as key defense against evolving infectious bursal disease strains
Research presented at the World's Poultry Congress examined 1,500 IBD virus sequences to understand how vaccination programs protect against diverse variants circulating in North America. Early infection within the first two weeks of a bird's life causes significant immune suppression, making breeder vaccination and maternal immunity critical for protecting young chicks. Strategic use of diverse vaccine approaches during the vulnerable early period can substantially reduce disease impact and secondary infections in poultry flocks.
Infectious bursal disease poses a particular threat to poultry operations because the virus suppresses immune function during a critical developmental window. When chicks contract IBD within their first two weeks of life, they become vulnerable not only to the disease itself but also to secondary infections and other illnesses that exploit their compromised immunity. This cascade of health problems can result in reduced growth rates and overall flock performance.
Understanding the virus requires examining its genetic variation across regions. Scientists identified approximately 10 to 12 distinct antigenic variants currently present in U.S. poultry populations, a diversity that has expanded over recent decades. This evolution means vaccination strategies must account for multiple circulating strains rather than relying on approaches designed solely for historical IBD variants, necessitating more sophisticated immunization planning.
IBD vaccine strategies could significantly affect poultry production costs and food supply stability. Producers implementing diverse vaccination approaches may face higher disease management expenses, potentially influencing pricing in the broiler and breeder chicken markets. Conversely, effective early-life protection could reduce losses from immune suppression and secondary infections, offsetting treatment costs. The findings may influence vaccination policy across commercial operations, affecting both large producers and smaller farms depending on their access to varied vaccine formulations and breeder vaccination programs.